Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)
6.94
+0.08 (1.17%)
Feb 3, 2026, 3:04 PM CST
SHE:002198 Revenue
Guangdong Jiaying Pharmaceutical had revenue of 94.50M CNY in the quarter ending September 30, 2025, with 19.01% growth. This brings the company's revenue in the last twelve months to 410.00M, down -1.35% year-over-year. In the year 2024, Guangdong Jiaying Pharmaceutical had annual revenue of 376.17M, down -29.46%.
Revenue (ttm)
410.00M
Revenue Growth
-1.35%
P/S Ratio
8.59
Revenue / Employee
690.23K
Employees
594
Market Cap
3.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 376.17M | -157.07M | -29.46% |
| Dec 31, 2023 | 533.23M | -125.96M | -19.11% |
| Jan 1, 2023 | 659.20M | 84.48M | 14.70% |
| Jan 1, 2022 | 574.71M | 29.98M | 5.50% |
| Dec 31, 2020 | 544.73M | 44.22M | 8.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Int'l Group | 33.54B |
| Zhejiang Zhenyuan Share | 2.67B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.88B |
| Chongqing Lummy Pharmaceutical | 771.02M |
| Hangzhou Minsheng Healthcare | 744.06M |
| Hubei Guangji Pharmaceutical | 605.87M |
| Hangzhou Bio-Sincerity Pharma-Tech | 590.33M |
| Zhejiang Haisen Pharmaceutical | 510.33M |